James C. Foster's Insider Trades & SAST Disclosures
James C. Foster's most recent trade in Charles River Laboratories International Inc. was a trade of 6,075 Common Stock done at an average price of $165.0 . Disclosure was reported to the exchange on Feb. 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern James C. Foster.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Purchase of securities on an exchange or from another person at price $ 165.01 per share. | 20 Feb 2025 | 6,075 | 183,639 (0%) | 0% | 165.0 | 1,002,436 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2025 | 19,608 | 204,391 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 165.57 per share. | 31 Jan 2025 | 6,827 | 197,564 (0%) | 0% | 165.6 | 1,130,346 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 08 Nov 2024 | 4,500 | 184,783 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 12 Aug 2024 | 2,500 | 185,751 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 250.00 per share. | 01 Aug 2024 | 25,000 | 188,251 (0%) | 0% | 250 | 6,250,000 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 24,858 | 24,858 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 214.51 per share. | 29 May 2024 | 1,274 | 223,044 (0%) | 0% | 214.5 | 273,286 | Common Stock |
| ZeroFox Holdings Inc | James Christopher Foster | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 1.12 per share. | 18 Mar 2024 | 80,542 | 10,370,476 | - | 1.1 | 90,207 | Common Stock |
| Charles River Laboratories... | Foster James C. | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 16 Feb 2024 | 4,000 | 224,613 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Foster C. James | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 24,253 | 239,370 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2024 | 23,741 | 238,858 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | Foster James C. | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.67 per share. | 29 Jan 2024 | 17,436 | 227,827 (0%) | 0% | 144.7 | 2,522,466 | Common Stock |
| Charles River Laboratories... | C. James Foster | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Jan 2024 | 17,436 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | James Foster C. | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.56 per share. | 29 Jan 2024 | 12,710 | 215,117 (0%) | 0% | 224.6 | 2,854,158 | Common Stock |
| Charles River Laboratories... | Foster C. James | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 10,757 | 228,613 (0%) | 0% | 220.3 | 2,369,552 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 220.28 per share. | 29 Jan 2024 | 10,540 | 228,318 (0%) | 0% | 220.3 | 2,321,751 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Purchase of securities on an exchange or from another person at price $ 178.05 per share. | 14 Nov 2023 | 5,620 | 202,643 (0%) | 0% | 178.1 | 1,000,641 | Common Stock |
| ZeroFox Holdings Inc | James Christopher Foster | Director, CEO and Chairman | Sale of securities on an exchange or to another person at price $ 1.19 per share. | 10 Aug 2023 | 76,859 | 9,951,018 | - | 1.2 | 91,462 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 10 Aug 2023 | 2,500 | 197,023 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 May 2023 | 28,176 | 28,176 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 194.12 per share. | 26 May 2023 | 1,274 | 199,523 (0%) | 0% | 194.1 | 247,309 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2023 | 3,812 | 6,017 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 15 May 2023 | 3,811 | 9,829 (0%) | 0% | 0 | Common Stock | |
| ZeroFox Holdings Inc | James Christopher Foster | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 1,003,649 | 9,526,053 | - | 0 | Common Stock | |
| ZeroFox Holdings Inc | James Christopher Foster | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Mar 2023 | 501,824 | 10,027,877 | - | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 243.60 per share. | 22 Feb 2023 | 1,814 | 214,780 (0%) | 0% | 243.6 | 441,890 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 250.00 per share. | 15 Feb 2023 | 19,892 | 216,702 (0%) | 0% | 250 | 4,973,000 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 250.16 per share. | 15 Feb 2023 | 108 | 216,594 (0%) | 0% | 250.2 | 27,017 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 49,725 | 254,375 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Jun 2022 | 21,453 | 232,922 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Jun 2022 | 2,000 | 211,711 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2022 | 24,042 | 24,042 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.41 per share. | 27 May 2022 | 1,311 | 213,711 (0%) | 0% | 244.4 | 320,422 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2022 | 20,296 | 0 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 109.34 per share. | 23 Feb 2022 | 20,296 | 235,318 (0%) | 0% | 109.3 | 2,219,165 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 287.84 per share. | 23 Feb 2022 | 4,245 | 220,957 (0%) | 0% | 287.8 | 1,221,889 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 284.79 per share. | 23 Feb 2022 | 3,415 | 230,400 (0%) | 0% | 284.8 | 972,542 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 287.10 per share. | 23 Feb 2022 | 3,171 | 225,202 (0%) | 0% | 287.1 | 910,388 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 286.06 per share. | 23 Feb 2022 | 2,027 | 228,373 (0%) | 0% | 286.1 | 579,845 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 283.89 per share. | 23 Feb 2022 | 1,503 | 233,815 (0%) | 0% | 283.9 | 426,683 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 291.05 per share. | 23 Feb 2022 | 1,259 | 217,815 (0%) | 0% | 291.1 | 366,436 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 290.01 per share. | 23 Feb 2022 | 1,078 | 219,074 (0%) | 0% | 290.0 | 312,633 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 291.81 per share. | 23 Feb 2022 | 981 | 216,834 (0%) | 0% | 291.8 | 286,263 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 288.82 per share. | 23 Feb 2022 | 805 | 220,152 (0%) | 0% | 288.8 | 232,501 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 292.87 per share. | 23 Feb 2022 | 746 | 216,088 (0%) | 0% | 292.9 | 218,478 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 294.70 per share. | 23 Feb 2022 | 389 | 215,374 (0%) | 0% | 294.7 | 114,637 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 295.70 per share. | 23 Feb 2022 | 352 | 215,022 (0%) | 0% | 295.7 | 104,085 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 293.81 per share. | 23 Feb 2022 | 325 | 215,763 (0%) | 0% | 293.8 | 95,489 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 144.67 per share. | 22 Feb 2022 | 17,436 | 234,228 (0%) | 0% | 144.7 | 2,522,466 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Feb 2022 | 17,436 | 17,436 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 288.12 per share. | 22 Feb 2022 | 5,243 | 225,795 (0%) | 0% | 288.1 | 1,510,588 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 288.86 per share. | 22 Feb 2022 | 4,472 | 221,323 (0%) | 0% | 288.9 | 1,291,763 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 290.03 per share. | 22 Feb 2022 | 2,600 | 218,723 (0%) | 0% | 290.0 | 754,085 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 286.93 per share. | 22 Feb 2022 | 2,394 | 231,038 (0%) | 0% | 286.9 | 686,919 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 289.58 per share. | 22 Feb 2022 | 1,770 | 215,022 (0%) | 0% | 289.6 | 512,557 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 293.61 per share. | 22 Feb 2022 | 1,610 | 216,792 (0%) | 0% | 293.6 | 472,712 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 290.89 per share. | 22 Feb 2022 | 1,481 | 217,242 (0%) | 0% | 290.9 | 430,802 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 285.88 per share. | 22 Feb 2022 | 796 | 233,432 (0%) | 0% | 285.9 | 227,561 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 292.74 per share. | 22 Feb 2022 | 350 | 216,792 (0%) | 0% | 292.7 | 102,460 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 291.50 per share. | 22 Feb 2022 | 100 | 217,142 (0%) | 0% | 291.5 | 29,150 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 314.43 per share. | 15 Feb 2022 | 2,812 | 226,753 (0%) | 0% | 314.4 | 884,179 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 310.35 per share. | 15 Feb 2022 | 2,456 | 234,557 (0%) | 0% | 310.4 | 762,226 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 316.34 per share. | 15 Feb 2022 | 2,157 | 222,780 (0%) | 0% | 316.3 | 682,353 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 312.19 per share. | 15 Feb 2022 | 1,835 | 231,079 (0%) | 0% | 312.2 | 572,872 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 315.15 per share. | 15 Feb 2022 | 1,816 | 224,937 (0%) | 0% | 315.2 | 572,314 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 311.30 per share. | 15 Feb 2022 | 1,643 | 232,914 (0%) | 0% | 311.3 | 511,466 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 313.24 per share. | 15 Feb 2022 | 1,514 | 229,565 (0%) | 0% | 313.2 | 474,245 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 317.06 per share. | 15 Feb 2022 | 1,243 | 221,537 (0%) | 0% | 317.1 | 394,103 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 309.36 per share. | 15 Feb 2022 | 1,064 | 237,013 (0%) | 0% | 309.4 | 329,164 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 331.43 per share. | 15 Feb 2022 | 914 | 218,704 (0%) | 0% | 331.4 | 302,931 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 330.16 per share. | 15 Feb 2022 | 465 | 219,618 (0%) | 0% | 330.2 | 153,526 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 320.23 per share. | 15 Feb 2022 | 420 | 220,792 (0%) | 0% | 320.2 | 134,496 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 308.23 per share. | 15 Feb 2022 | 325 | 238,077 (0%) | 0% | 308.2 | 100,174 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 317.98 per share. | 15 Feb 2022 | 325 | 221,212 (0%) | 0% | 318.0 | 103,344 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 333.29 per share. | 15 Feb 2022 | 236 | 218,417 (0%) | 0% | 333.3 | 78,657 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 326.88 per share. | 15 Feb 2022 | 179 | 220,339 (0%) | 0% | 326.9 | 58,511 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 323.07 per share. | 15 Feb 2022 | 174 | 220,518 (0%) | 0% | 323.1 | 56,214 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 329.12 per share. | 15 Feb 2022 | 158 | 220,083 (0%) | 0% | 329.1 | 52,001 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 321.93 per share. | 15 Feb 2022 | 100 | 220,692 (0%) | 0% | 321.9 | 32,193 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 328.50 per share. | 15 Feb 2022 | 98 | 220,241 (0%) | 0% | 328.5 | 32,193 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 332.63 per share. | 15 Feb 2022 | 51 | 218,653 (0%) | 0% | 332.6 | 16,964 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 334.07 per share. | 15 Feb 2022 | 15 | 218,402 (0%) | 0% | 334.1 | 5,011 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Oct 2021 | 65,011 | 263,510 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 312.24 per share. | 26 Oct 2021 | 25,108 | 238,402 (0%) | 0% | 312.2 | 7,839,722 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 26 Oct 2021 | 14,813 | 0 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 400.89 per share. | 06 Aug 2021 | 3,822 | 208,477 (0%) | 0% | 400.9 | 1,532,197 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 401.77 per share. | 06 Aug 2021 | 3,718 | 204,759 (0%) | 0% | 401.8 | 1,493,798 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 06 Aug 2021 | 2,500 | 212,299 (0%) | 0% | 0 | Common Stock | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 402.71 per share. | 06 Aug 2021 | 1,552 | 203,207 (0%) | 0% | 402.7 | 625,007 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 403.92 per share. | 06 Aug 2021 | 808 | 202,399 (0%) | 0% | 403.9 | 326,364 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 405.00 per share. | 06 Aug 2021 | 100 | 202,299 (0%) | 0% | 405 | 40,500 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 179.66 per share. | 01 Jun 2021 | 9,577 | 224,376 (0%) | 0% | 179.7 | 1,720,604 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 9,577 | 28,733 | - | - | Stock Options (Right to Buy) | |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 331.95 per share. | 01 Jun 2021 | 4,551 | 217,735 (0%) | 0% | 331.9 | 1,510,699 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 333.02 per share. | 01 Jun 2021 | 1,638 | 216,097 (0%) | 0% | 333.0 | 545,488 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 330.07 per share. | 01 Jun 2021 | 1,189 | 222,714 (0%) | 0% | 330.1 | 392,453 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 333.97 per share. | 01 Jun 2021 | 503 | 215,594 (0%) | 0% | 334.0 | 167,986 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 329.18 per share. | 01 Jun 2021 | 473 | 223,903 (0%) | 0% | 329.2 | 155,701 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 331.13 per share. | 01 Jun 2021 | 428 | 222,286 (0%) | 0% | 331.1 | 141,723 | Common Stock |
| Charles River Laboratories... | James C. Foster | Director, Chairman, President and CEO | Sale of securities on an exchange or to another person at price $ 338.27 per share. | 01 Jun 2021 | 316 | 214,838 (0%) | 0% | 338.3 | 106,893 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges